Thu, 23 May 2019 15:40:54: GSK tweaks ethics-based rep compensation rules to recruit and retain talent

Thu, 23 May 2019 14:31:14: Want bang for your buck? Don't look to Sarepta's pricey DMD therapy Exondys, ICER says

Thu, 23 May 2019 13:31:11: Daiichi Sankyo looking to sell OTC business for $900M? 'Not correct,' says company

Thu, 23 May 2019 13:22:14: J&J's Invokana closes in on badly needed kidney disease nod with FDA 'priority' boost

Thu, 23 May 2019 13:11:16: Novartis CEO says Zolgensma won't cost anywhere near the $4M to $5M once quoted

Thu, 23 May 2019 12:04:53: Boehringer Ingelheim plans 3-year, $84M expansion in Mexico

Thu, 23 May 2019 02:03:04: Dendreon commits to prostate cancer vaccine Provenge with new lease for manufacturing site

Wed, 22 May 2019 14:49:17: Array's ‘extremely compelling’ new colon cancer data spark blockbuster talk

Wed, 22 May 2019 14:01:36: Lilly to insulin pricing critics: Check out our 50%-off Humalog copy instead

Wed, 22 May 2019 13:54:13: Daiichi Sankyo comes up far short of promised avian flu vaccine production

Wed, 22 May 2019 13:24:21: J&J's good news, bad news day in talc court yields win in South Carolina, $25M loss in New York

Wed, 22 May 2019 13:19:03: GlaxoSmithKline's booming Shingrix, after VIP invite, wins nod to tackle China

Tue, 21 May 2019 15:30:43: Baltimore sues J&J for spinning up a 'sham' Zytiga patent to fend off generics

Tue, 21 May 2019 14:43:33: WuXi to build dedicated vaccine facility, but who's the client?

Tue, 21 May 2019 14:00:26: Supreme Court puts Merck's FDA preemption argument up for another review

Tue, 21 May 2019 13:41:13: See you in court: Mallinckrodt takes on feds to fight $600M in back Acthar rebates

Tue, 21 May 2019 13:30:28: Seattle Genetics taps pharma oncology veteran as first-ever chief commercial officer

Tue, 21 May 2019 13:04:48: Merck's powerhouse Keytruda whiffs breast cancer trial, delaying hopes for new use

Tue, 21 May 2019 12:37:25: Catalent's new prize, Paragon, adding capacity to make Sarepta gene therapies

Mon, 20 May 2019 14:31:49: Hurting for revenue, Mylan shells out $130M for basket of Aspen drugs

Mon, 20 May 2019 14:21:36: AbbVie's discounting Humira to aid Skyrizi's launch—and a price war could follow: analyst

Mon, 20 May 2019 14:18:02: CSL Behring poaches top manufacturing executive from struggling Biogen

Mon, 20 May 2019 13:28:46: 'Cornucopia' of biopharma innovation blurs drug launch forecasts, analyst laments

Mon, 20 May 2019 12:40:20: J&J targets different audiences with Xarelto TV commercial trio

Mon, 20 May 2019 12:14:32: AstraZeneca's Fasenra offers severe asthma patients 2 years of benefits: analysis